Because BIG PCR happens in miniaturized packages

Video

In today's scientific environment, the pressure is on to do more with less. And how do you do that? With miniaturization. Miniaturization is the key for doing more with less in the life science industry. When you miniaturize reactions, you: . minimize sample volume . lower reagent cost . boost throughput Watch a short video of Dr. Luke Linz, LGC Laboratory Operations Manager, explaining how miniaturization works!

Watch Now

Analyze Glycans Up To 5X Faster than HILIC

Video

Obtaining high resolution glycan data has traditionally required patience. Typical analysis methods can take up to a full day. Not any longer. SCIEX Fast Glycan Labeling and Analysis delivers rapid glycan heterogeneity identification, capable of profiling your glycans in record time. Combining simplified sample preparation, rapid separations and automated glycan identification, you can make confident decisions quickly by running glycans up to five-times faster than HILIC.

Watch Now

Microfluidics for Single Cell Analysis of CTCs

Article

Here we take a look at the use of microfluidic devices in the isolation and analysis of circulating tumor cells.

Read more
Researchers Revolutionize Brain-Computer Interfaces Using Silicon Electronics

Researchers Revolutionize Brain-Computer Interfaces Using Silicon Electronics

News

In new DARPA project, researchers exploit the latest in silicon electronics to invent an implanted brain-interface device that could transform how artificial systems enhance brain functions.

Read more
 
Innate Reaction of Hematopoietic Stem Cells to Severe Infections
News

Researchers at the University of Zurich have shown for the first time that hematopoietic stem cells detect infectious agents themselves and begin to divide, without signals from growth factors.

Read more

Cow Antibodies Yield Important Clues For Developing A Broadly Effective AIDS Vaccine
News

The unexpected animal model is providing clues for important questions at a moment when new energy has infused HIV vaccine research.

Read more

CRISPR Reveals New Targets for Promising Cancer Drugs
News

Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.

Read more